Thomas Marron, MD, PhD
img_Thomas Marron
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Cancer (Oncology)

PhD, Mount Sinai School of Medicine of New York University

MD, Icahn School of Medicine at Mount Sinai

Residency, Internal Medicine, Mount Sinai Hospital and Medical Center

Fellowship, Medical Oncology, Mount Sinai Hospital and Medical Center

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation. Xucheng Hou, Chang Wang, Yichen Zhong, Leiming Wang, Diana D. Kang, Gabrielle Lubitz, Yonger Xue, Zhengwei Liu, Siyu Wang, Haoyuan Li, Meng Tian, Dinglingge Cao, Kaiyuan Guo, Binbin Deng, David W. McComb, Thomas U. Marron, Brian D. Brown, Miriam Merad, Joshua D. Brody, Yizhou Dong. Journal of Controlled Release

Financial Toxicity Among Patients With Advanced Solid Tumors Participating in Early-Phase Clinical Trials. Julia Blanter, Grace Van Hyfte, Maham Ahmad, Suzanne Xu, Olivia Hapanowicz, Gabriela Fazilov, Ashley Lu, Natalie Lucas, Kathy Wu, Gary Shelton, Mandy Demerchant, Michael Lachowicz, Melanie Kier, Michael Werner, Joseph P. Eder, Matthew D. Galsky, Thomas U. Marron, Cardinale B. Smith, Patricia M. Lorusso, Erin Hofstatter, Deborah B. Doroshow. JCO Oncology Practice

Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients. Adriana P.C. Barrichello, Arielle Elkrief, Biagio Ricciuti, Teja Ganta, Thomas U. Marron, Xinan Wang, William Lotter, James Lindsay, Valentina Santo, Alessio Cortellini, Bijaya Sharma, Kristen Felt, Kathleen Pfaff, Giuseppe Lamberti, Federica Pecci, Alessandro Di Federico, Maisam Makarem, Malini M. Gandhi, Tom Nguyen, Danielle Haradon, Victor R. Vaz, Bruce E. Johnson, Neha Debnath, Yinghong Wang, Andrew G. Kuang, Anwaar Saeed, Maluki Radford, Christine M. Lovly, Caroline A. Nebhan, David J. Pinato, Scott J. Rodig, Adam J. Schoenfeld, Mark M. Awad, Joao V. Alessi, Abdul Rafeh Naqash. Clinical Lung Cancer

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Marron during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Regeneron Pharmaceuticals
  • Astellas Pharma Inc.
  • Storm
  • Merck & Co., Inc.
  • TUBULIS
  • Ono Pharmaceuticals
  • Geneos Therapeutics, Inc,
  • Replimune
  • EMD Serono, Inc
  • AbbVie Biotherapeutics, Inc.
  • Arrowhead Research Corporation
  • NTx Natures Toolbox

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.